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ABSTRACT
Skins infections caused by Mycobacterium marinum occur only rarely. We report one case 
of chronic and extensive M. marinum cutaneous infection simulating chromoblastomycosis 
and review the pertinent literature. A 52-year-old farmer reported a 32-year chronic skin 
problem on his right lower limb, resulting from contact with cacti. It consisted of skin lesion 
presenting with dyschromic atrophic center plate and verrucous borders with hematic crusts, 
extending from the knee anteriorly to the inferior third of the right leg. Mycobacterium 
marinum infection was detected by histopathological examination of a skin fragment, culture 
for mycobacteria and genetic mapping of the culture material. The patient was successfully 
treated with Ethambutol, Rifampicin and Trimethoprim-Sulfamethoxazole. The clinical 
and histopathological findings of M. marinum infection is nonspecific showing clinical 
polymorphism and bacilli are rarely evident on histopathological examination. Given these 
difficulties, it is essential to perform tissue culture in a suspicious case and it is important 
keep this infection in mind in patients with long-lasting indolent verrucous lesions and a 
history of exposure to sea water, freshwater, aquaria or fish.
KEYWORDS: Atypical mycobacteria. Non-tuberculous mycobacteria. Mycobacterium 
marinum.
INTRODUCTION
Cutaneous infections caused by Mycobacterium marinum (Mma), a member 
of the nontuberculous mycobacteria (NTM) group, is a rare disease. M. marinum 
virtually always causes cutaneous disease through direct inoculation, typically 
following traumatic injuries caused by a contaminated environmental source1,2.
The manifestations include granulomatous lesions, predominantly acral in 
distribution, that affect patients regardless of their immune status. Clinical and 
histopathological findings are non-specific, consisting of papules, nodules or 
erythematous plaquesand the presence of tuberculous granulomas with little 
evidence of bacilli on examination. Due to diagnostic difficulties, going from the 
infrequent distribution and the plurality of clinical presentations, M. marinum can 
cause erythematous to plate-shaped, papules, nodules, single or multiple ulcerations 
and even sporotrichosis-like presentations, making the differential diagnosis with 
other granulomatous lesions essential3.
The infection in humans, due to contact with contaminated water or 
fish is comparatively rare with an incidence of 0.04 to 0.27 cases per 
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100,000 inhabitants per year4. First described as a 
“swimming-pool granuloma”, M. marinum skin infection 
is nowadays acquired in the maintenance of aquariums 
and, therefore, is called “fish tank granuloma” or aquarium 
granuloma5.
Mycobacterium marinum is an acid-fast, aerobic, not 
mobile, non-sporulating, photochromogen bacterium with 
a thick cell wall made up of wax (40-70%) and lipids 
(25-30%). Mycobacterium marinum growth is usually slow, 
takingtwo to six weeks on Lowenstein–Jensen medium 
at 25-33 °C. By using light source in culture, the color 
changes from white to yellow because of the accumulation 
of β-carotene crystals. It has a worldwide diffusion, mainly 
in temperate and hot-humid climate, living in aquatic 
environments, especially in salt water and aquariums or 
pools4,6. This mycobacterium can infect cold-blooded 
animals such as turtles, amphibians and snakes, causing 
chronic systemic infection in fish4,7. Dead fish can serve, 
as well, as reservoirs4,8.
The diagnosis can be made by histological examination 
and identification of M. marinum in a culture of a fragment 
of a lesion fragment sown in Löwenstein-Jensen medium. 
The organisms isolated from the lesion, as well as from the 
patient’s colonies are smooth, shiny and creamy colored, 
turning yellow under exposure to light (photochromogenic). 
Faster identification may be achieved by the polymerase 
chain reaction9. Dermatoscopic characteristics of a 
microbiologically-proven M. marinum skin infection can 
be used in the future to establish very early diagnosis of 
this infection, reducing the diagnostic delay10. 
Here we report one case of atypical M. marinum 
cutaneous infection from an injury caused by contact with 
a cactus and review the pertinent literature.
CASE REPORT
A 52-year-old black male farmer from a rural area in 
Northeastern Brazil was referred to our outpatient infectious 
diseases clinic because of skin plaques after a trauma caused 
by a cactus thorn on his right leg 32 years before. He was 
otherwise healthy and mentioned bathing in ponds, fishing 
activities and handling fish for his own consumption. The 
plaque had a dyschromic atrophic center and erythematous-
violaceous infiltrated verrucous borders with hematic crusts 
extending anteriorly from the upper border of the right knee 
to the lower third of the right leg (Figures 1A and 1B). He 
denied systemic symptoms, renal and hepatic functions, 
blood countand lipid profiles were within normal limits. 
A skin ellipse biopsy of the right leg was performed and 
showed a chronic inflammatory process in the superficial 
and deep dermis associated with pseudo-epitheliomatous 
hyperplasia (Figures 2A and 2B). Direct search for fungus 
and mycobacteria with Periodic acid-Schhiff (PAS) and 
Fite-Faraco, respectively, were negative (Figure 2C). A 
fungal culture was also negative. A mycobacteria culture 
in Ogawa Kudoh medium was positive (Figure 3) and 
M. marinum was identified through a Polymerase Chain 
Reaction (PCR) followed by a Restriction Enzyme Analysis 
(REA).
The patient received a combined treatment for six months 
composed of ethambutol 400 mg three times a day for three 
months, rifampicin 300 mg twice daily for six months and 
trimethoprim-sulfamethoxazole (160 mg + 800 mg) twice 
daily for six months; topical treatment was not performed. 
The verrucous lesions disappeared (Figure 1C), leaving a 
dystrophic atrophic plaque in the affected region, with no 
relapse to date.
Figure 1 - Erythematous-violaceous infiltrated verrucous borders lesion with hematic crusts extending anteriorly from the upper 
border of the right knee to the lower third of the right leg (A) and a plaque with a dyschromic atrophic center (B). Regression of 
cutaneous lesions six months after the beginning of treatment with an atrophic plaque in the entire region, previously affected, on 
right lower limb (C).
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DISCUSSION
The genus Mycobacterium comprises more than 177 
species including pathogenic, opportunistic pathogens 
and non-pathogenic environmental species, most of 
which have been incriminated in skin and soft tissues 
infections. Mycobacteria are free-living, acid-fast, robust 
organisms that can survive and even thrive in widely 
diverse environments such as soil and tap water to animals 
and humans consumption. Of interest to this study, 
M. marinum was first described in 1926 by Joseph D. 
Aronson. The bacterium was isolated from fish presenting 
with mycobacteriosis infection and exhibiting similarities 
with tuberculosis in humans. Later, it was shown that 
M. marinum could also infect humans and cause skin 
lesions at the extremities of the limbs11. Scientific interest 
in M. marinum is mainly due to its genetic relatedness 
to M. tuberculosis, and it is a model for tuberculosis 
pathogenesis12.
The retrospective study in Denmark performed from 
January 1st, 2004 to May 31st, 2017 identified 55 patients 
with culture-positive M. marinum infections. Men 
comprised 71.7% of patients with a median age of 49 years. 
Almost all patients had a history of aquatic exposure, 
predominately the maintenance of fish tank
Mycobacterium marinum infection usually occurs in 
immunocompetent patients with minor trauma followed by 
contact with an infected animal or handling of contaminated 
aquariums or water3. In immunocompetent patients lesions 
are usually solitary, a red-to-violaceous plaque or nodule 
with an overlying crust or verrucous surface that may 
ulcerate. Inflammatory nodules or abscesses can develop 
in severely immunosuppressed patient, usually in a type of 
distribution of sporotrichosis9. Our patient had been injured 
via puncture by a cactus spine to the knee. M. marinum 
can also cause an opportunistic infection, primarily in 
immune deficient patients, such as those with the human 
immunodeficiency virus (HIV)/acquired immunodeficiency 
syndrome (AIDS). 
Mycobacterium marinum infection has polymorphic 
clinical presentations. Initially, a solitary erythematous 
papule or nodule will appear at the site of inoculation, often 
on an extremity, particularly the hand. This can progress 
to a verrucous violaceus plaque and/or ulcerate lesion 
producing a serosanguineous discharge, and in 29% of the 
cases, bacteria can invade deeper tissues, such as tendon 
sheaths, bursae, bones and joints. There a are four clinical 
Figure 2 - Chronic inflammatory process in the superficial and deep dermis associated with pseudo-epitheliomatous hyperplasia 
with negative Periodic acid-Schhiff (PAS) (A, B). Acid-fast Bacilli (AFB) by Fite-Faraco negative to mycobacteria (C).
Figure 3 - Biopsy culture in Ogawa Kudoh medium culture 
showing colonies of M. marinum.
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categories according to the severity of infections: localized 
superficial cutaneous lesions (type I), nodular lymphangitis 
sometimes with nodules, abscesses and granulomas 
(type II), deeper infections with or without skin involvement 
(type III) and M. marinum disseminated infection with lung 
involvement and other systemic manifestations (type IV). 
Bacteremia is exceedingly rare but may occur in severely 
immunocompromised patients. Other sites of M. marinum 
infection have also been reported. Severe intranasal 
lesions resulting from M. marinum infections, while the 
disseminated infection comprises the skin, lungs and other 
viscera and the larynx12,13.
Our patient had a 32-year history of a large verrucous 
plaque remarkably similar to chromomycosis. Lillis et al.14 
reported a 29-year-old male South Pacific Islander with 
an 18-year history of a similar lesion on the left leg, 
simulating psoriasis, chromomycosis or tuberculosis 
verrucose cutis. Lee and Brennan15 published some cases 
of otherwise healthy South Pacific Islanders with chronic 
lesions (more than 20 years) of verrucous plaques on the 
lower extremities.
In France, 63 cases of culture-confirmed M. marinum 
infections were studied from January 1, 1996, to December 
31, 1998. Nodules were observed in 41 (67%) of the 
63 patients, including a sporotrichoid aspect in 16 (39% 
of the nodules). Other skin lesions were ulcers, abscesses 
and pustules. Adenitis was observed in 10 patients16. It is 
noteworthy that the skin lesions caused by M. marinus 
in our case were not reported in the other case studies, 
demonstrating that this characteristic is rare.
Skin lesions of non-tuberculous mycobacteria often 
go misdiagnosed. Mycobacterium marinum infection is a 
diagnosis that must be considered as a differential diagnosis 
with wart tuberculosis, sporotrichosis, chromomycosis, 
squamous cell carcinoma, leishmaniasis, tularemia, 
sarcoidosis and reactions to foreign bodies, as the growth of 
mycobacterium marinus is slow, delaying the diagnosis and 
treatment17. As our case shows, the same immunocompetent 
patient suffered 32 years with the infection and had a 
considerable delay in the diagnosis.
A delay between the onset of injuries and the patient’s 
seeking medical attention is due to the fact that the infection 
is indolent, and the lesions are painless. The diagnosis of M. 
marinum infection is often delayed, due to its low prevalence 
and because there are few specific clinical signs and 
symptoms. Thus, many patients initially receive incorrect 
diagnoses and inappropriate treatments18. Biopsies for tissue 
cultures and histopathologic examination are essential for 
the diagnosis8. Common histopathological patterns include 
granulomatous inflammatory infiltrates. Microscopic 
examination of the specimen after Ziehl-Neelsen staining 
is positive in 30% of the cases. A definitive diagnosis is 
obtained by the finding of a positive culture that occurs in 
70-80% of the cases. After isolation of a photochromogenic 
Mycobacterium, molecular identification using DNA 
analysis is necessary12. In our case, the REA method 
was used. PCR amplification and restriction enzyme 
analysis (PCR-REA), hybridization with species-specific 
oligonucleotide probes (with or without prior DNA 
amplification) and nucleic acid sequencing have shown 
to identify a limited number of Mycobacterium strains19.
Mycobacterium marinum isolates are susceptible 
to rifampin, rifabutin and ethambutol; intermediately 
susceptible to streptomycin; and resistant to isoniazid and 
pyrazinamide. Isolates are also susceptible to clarithromycin, 
sulfonamides or trimethoprim sulfamethoxazole, and 
susceptible or intermediately susceptible to doxycycline and 
minocycline. A reasonable approach is a treatment regimen 
composed of two active agents for 1 to 2 months after 
resolution of symptoms, typically 3 to 4 months. In a French 
study, the combination of clarithromycin and rifampin for 
an average of 3.5 months resolved infections in 93% of 
the patients with localized forms and in 72% of those with 
deep structure involvement (e.g., osteomyelitis). Treatment 
failure was related to deep structure involvement, but not 
to any antibiotic regimen. Clarithromycin and ethambutol 
are likely to provide the optimal balance of efficacy and 
tolerability for most patients, with the addition of rifampin 
in cases of osteomyelitis or other deep structure infection20. 
Experience in treatment of other NTM suggests 
that azithromycin may be a reasonable alternative to 
clarithromycin. Susceptibility tests are not routinely 
recommended and should be reserved for cases of 
treatment failure. Resection and debridement of the lesion 
are generally not recommended and are only indicated in 
cases refractory to treatment with antibiotics. Some studies 
showed worsening of conditions when resections and 
debridement were carried out. Evidently, the intervention 
may be indicated as an adjunctive treatment in cases of 
tissue necrosis and septic arthritis, facilitating the effects of 
antibiotics20. Cryotherapy, laser and photodynamic therapy 
have been reported as effective treatment alternatives, but 
there are few studies evaluating the efficiency of these 
methods6.
CONCLUSION
Mycobacterium marinum is considered an uncommon 
cause of skin infection in humans. The diagnosis requires a 
high index of suspicion. This infection should be included 
in the differential diagnosis of chronic verrucous plaques on 
the extremities, especially if there is a history of exposure 
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to fresh, salt water or marine animals. Further studies are 
needed to understand its clinical polymorphism with some 
patients showing spontaneous cure, while others develop 
long-term diseases.
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